Close
Almac
Achema middle east

Tag: Treatments

Regeneron Looks to Infusing More Funds into Gene Editing

Regeneron Pharmaceuticals is going ahead and investing more funds into gene editing, as it has announced a collaboration with Tessera Therapeutics in December 2025,...

FDA Looks to Accelerate Biosimilar Drug Development

The FDA has gone on to propose certain new policies in order to accelerate biosimilar drug development and at the same time also lower...

Aptar Digital Health Announces FDA 510(k) Clearance for HeroTracker® Sense, a Connected Add-On Device for MeteredDose Inhalers

Aptar Digital Health, a global leader in digital health solutions enhancing the patient experience, today announced that the U.S. Food and Drug Administration (FDA)...

Thermo Fisher Scientific to Accelerate Life Science Breakthroughs with OpenAI

Thermo Fisher Scientific Inc., the world leader in serving science, announced plans to further increase the impact of Thermo Fisher’s proven growth strategy through...

Merck to Initiate Phase 3 Trials for Investigational Once-Monthly HIV Prevention Pill

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the EXPrESSIVE Phase 3 clinical trials,...

End-To-End Solutions in Pharma Logistics Creating Difference

There is no shred of doubt that every stage of the pharmaceutical supply chain happens to be critical if the life-saving drugs are to...

Asia’s Bio Sovereignty: Nations Reclaiming Biologics Control

The biopharmaceutical industry in the Asia-Pacific area has seen a significant strategic shift in recent years; this trend is now commonly acknowledged as Asia's...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

Translate »